BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, ...

Highlights: Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral Sclerosis Orphan Designation offers 10 ...

RBC Capital analyst Leonid Timashev initiated coverage with a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of ... including a Phase 2b clinical trial in patients ...

While the Today show star is famous for his role on the NBC morning ... Shortly after he uploaded the snippet, the news ...

Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...

This event was also one of the first for the new USA Health Kelly Butler ALS Center. 2 men fall asleep in car after ...

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...

Barclays analyst Carter Gould maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $95.00.

Kamala Harris reveals how she unwinds, and offers a retort to Donald Trump about her intelligence, in a newly released ...

Three years ago, longtime stage actor Aaron Lazar was diagnosed with ALS, a degenerative disease that affects nerve cells ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, ...

The event aims to support those living with ALS and to fund research, advocacy, and care services. ALS, often referred to as Lou Gehrig’s disease, is a progressive neurodegenerative condition ...